Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.21.36 - pancreatic elastase

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Acantholysis
Acantholysis induced by proteolytic enzymes. I. Porcine pancreatic elastase.
Acquired Immunodeficiency Syndrome
Serum pancreatic enzymes in HIV-seropositive patients.
Acute Lung Injury
Differences in acute lung response to elastase instillation in two rodent species may determine differences in severity of emphysema development.
The effects of Gamijinhae-tang on elastase/lipopolysaccharide-induced lung inflammation in an animal model of acute lung injury.
[The role of interstitial hyaluronan in acute lung injury]
Adenocarcinoma
Clinical usefulness of computer-assisted diagnosis using combination assay of tumor markers for pancreatic carcinoma.
Obstructed pancreaticojejunostomy partly explains exocrine insufficiency after pancreatic head resection.
[Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9]
AIDS-Related Complex
Serum pancreatic enzymes in HIV-seropositive patients.
Albuminuria
The effect of pancreatic elastase on diabetic nephropathy.
alpha 1-Antitrypsin Deficiency
The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase.
Aneurysm
AMD3100 accelerates reendothelialization of neointima in rabbit saccular aneurysm after flow diverter treatment.
Arterial hypertension and aneurysmal dilatation.
Assessment of the role of pancreatic proteases in human abdominal aortic aneurysms and occlusive disease.
Comparison of elastolytic activity between experimental aneurysm and experimental diabetes mellitus.
Development of a new experimental model of saccular aneurysm by intra-arterial incubation of papain in rabbits.
Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model.
Extra- and Intraluminal Elastase Induce Morphologically Distinct Abdominal Aortic Aneurysms in Mice and Thus Represent Specific Subtypes of Human Disease.
Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic Reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression.
Peptide Inhibitor of CXCL4-CCL5 Heterodimer Formation, MKEY, Inhibits Experimental Aortic Aneurysm Initiation and Progression.
Phenotypic switching of vascular smooth muscle cells in animal model of rat thoracic aortic aneurysm.
Reversal of elastase-induced abdominal aortic aneurysm following the delivery of nanoparticle-based pentagalloyl glucose (PGG) is associated with reduced inflammatory and immune markers.
Stromal cell-derived factor 1? facilitates aneurysm remodeling in elastase-induced rabbit saccular aneurysm.
The production of aneurysms with pancreatic elastase.
Aortic Aneurysm
Elastase-induced experimental aneurysms in rats.
Hyperglycemia limits experimental aortic aneurysm progression.
Aortic Aneurysm, Abdominal
Acute mechanical effects of elastase on the infrarenal mouse aorta: implications for models of aneurysms.
Assessment of the role of pancreatic proteases in human abdominal aortic aneurysms and occlusive disease.
Creation of murine experimental abdominal aortic aneurysms with elastase.
Elastase is not sufficient to induce experimental abdominal aortic aneurysms.
H19 Induces Abdominal Aortic Aneurysm Development and Progression.
Long-Term Effects of the Abdominal Aortic Aneurysm Model in Rabbits Prepared by Pancreatic Elastase Combined With Angiotensin II.
Overexpression of TIMP-2 mediated by recombinant adenovirus in rat abdominal aorta inhibits extracellular matrix degradation.
Reversal of elastase-induced abdominal aortic aneurysm following the delivery of nanoparticle-based pentagalloyl glucose (PGG) is associated with reduced inflammatory and immune markers.
The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response.
Thermosensitive Hydrogel Containing Doxycycline Exerts Inhibitory Effects on Abdominal Aortic Aneurysm Induced By Pancreatic Elastase in Mice.
[18F]Fluorothymidine Uptake in the Porcine Pancreatic Elastase-Induced Model of Abdominal Aortic Aneurysm.
Arteriovenous Fistula
A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation.
Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.
Asthma
Effect of a Cysteinyl Leukotriene Receptor Antagonist on Experimental Emphysema and Asthma Combined with Emphysema.
Elastase/antielastase systems in pulmonary diseases.
Atherosclerosis
CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation.
Elastase in the prevention of arterial aging and the treatment of atherosclerosis.
Establishment of Rabbit Abdominal Aortic Atherosclerosis Model by Pancreatic Elastase Infiltration Associated with High Fat Diet.
[Pancreatic elastase and experimental atherosclerosis in chickens: biohumoral and histomorphological data.]
Balkan Nephropathy
NGS nominated CELA1, HSPG2, and KCNK5 as candidate genes for predisposition to Balkan endemic nephropathy.
Biliary Tract Neoplasms
[Tumor markers for pancreatic and biliary tract cancer]
Blister
The pathology of elastase-induced panacinar emphysema in hamsters.
Breast Neoplasms
The detection of serine elastase in human breast cancer.
Carcinoma
A potentially novel peptidase, resembling but distinct from neutrophil elastase, produced by carcinoma cells.
Effectiveness of discriminant analysis of serum CA 19-9 and elastase 1 in diagnosis of pancreatic carcinoma.
Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer.
Pancreatic ductal cell carcinoma producing pancreatic elastase 1.
Pancreatic elastase IIIA and its variants are expressed in pancreatic carcinoma cells.
Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma.
The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography.
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma.
[A promising tumor marker CA 19-9 for pancreatic carcinoma: comparison with CEA and elastase 1]
[Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9]
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
[Tumor marker--personal experience. Mass survey and outpatients screening of pancreatic cancer]
Carcinoma, Acinar Cell
A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.
Cholangiocarcinoma
Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis.
Cholera
Resistance of purified cholera toxin to enzymatic treatment with pancreatic elastase and papain.
Cholestasis
Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis.
Fecal elastase 1, serum amylase and lipase levels in children with cholestasis.
Normal levels of serum pancreatic enzymes in patients with progressive familial intrahepatic cholestasis type 2.
Colitis
Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis.
Colitis, Ulcerative
Pancreatic and granulocytic endoproteases in faecal extracts from patients with active ulcerative colitis.
Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.
Secretory leukocyte protease inhibitor in punch biopsies from human colonic mucosa.
[Exocrine function of the pancreas in patients with ulcerative colitis]
Crohn Disease
Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.
[Clinical features of different variants of excretory pancreatic insufficiency]
Cystadenocarcinoma
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Cystadenoma
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Cystic Fibrosis
A Comparison of Diagnostic Methods for Pancreatic Insufficiency in Infants with Cystic Fibrosis.
Analysis of pancreatic serum markers in patients with cystic fibrosis.
CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis.
Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis.
Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Evaluation of fecal pancreatic elastase-1 as a measure of pancreatic exocrine function in children with cystic fibrosis.
Faecal elastase 1 in children with cystic fibrosis.
Faecal elastase 1: a marker of exocrine pancreatic insufficiency in cystic fibrosis.
Faecal elastase-1 (EL-1) in pediatric patients with cystic fibrosis [Letter - Authors' reply].
Faecal elastase-1 (EL-1) in pediatric patients with cystic fibrosis.
Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Faecal elastase-1 concentration in cystic fibrosis patients with CFTR I1234V mutation.
Faecal elastase-1 test is superior to faecal lipase test in the assessment of exocrine pancreatic function in cystic fibrosis.
Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis.
Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease.
Fecal elastase-1 is superior to fecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis.
Fecal elastase-1: utility in pancreatic function in cystic fibrosis.
Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Fecal pancreatic elastase in infants under 2 years of age.
Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency.
Longitudinal follow-up of exocrine pancreatic function in pancreatic sufficient cystic fibrosis patients using the fecal elastase-1 test.
Pancreatic Elastase-1 Quick Test for rapid assessment of pancreatic status in cystic fibrosis patients.
Polyclonal versus monoclonal ELISA for the determination of fecal elastase 1: diagnostic value in cystic fibrosis and chronic pancreatic insufficiency.
Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.
Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis.
Use of monoclonal faecal elastase-1 concentration for pancreatic status assessment in cystic fibrosis patients.
Variability of fecal pancreatic elastase measurements in cystic fibrosis patients.
[Comparison of faecal lipase test and faecal elastase-1 test in the assessment of exocrine pancreatic function in cystic fibrosis]
Cysts
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Dehydration
Significance of increased serum elastase 1 level during the hyperosmolar hyperglycemic non-ketotic syndrome.
Diabetes Mellitus
Comment on "Lw fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (pancreas. 2008;36:274-278)".
Determinants of Exocrine Pancreatic Function as Measured by Fecal Elastase-1 Concentrations (FEC) in Patients with Diabetes mellitus.
Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus.
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients.
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.
Low faecal elastase 1 concentrations in type 2 diabetes mellitus.
Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
Low fecal elastase-1 in type I diabetes mellitus.
MRI and MRCP Findings of the Pancreas in Patients With Diabetes Mellitus: Compared Analysis With Pancreatic Exocrine Function Determined by Fecal Elastase 1.
Pancreatic Elastase Levels in Feces As A Marker of Exocrine Pancreatic Function in Patients With Diabetes Mellitus.
Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus.
Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial.
[DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
Diabetes Mellitus, Type 1
Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children.
Pancreas size and exocrine function is decreased in young children with recent-onset Type 1 diabetes.
Pancreatic exocrine function in patients with diabetes.
Diabetes Mellitus, Type 2
Association of faecal elastase 1 with non-fasting triglycerides in type 2 diabetes.
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.
Importance of pancreatic exocrine dysfunction in patients with type 2 diabetes: A randomized crossover study.
Inverse association of HbA1c with faecal elastase 1 in people without diabetes.
Low faecal elastase 1 concentrations in type 2 diabetes mellitus.
Nutritional markers in patients with diabetes and pancreatic exocrine failure.
Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus.
The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes.
[DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
Diabetic Nephropathies
Effect of pancreatic elastase on diabetic nephropathy.
The effect of pancreatic elastase on diabetic nephropathy.
Digestive System Diseases
Serum elastase 1 in clinical practice.
Duodenogastric Reflux
[THE GEPATOPANCREATOBILIARY SYSTEM AFTER CHOLECYSTECTOMY].
Exocrine Pancreatic Insufficiency
A Comparison of Diagnostic Methods for Pancreatic Insufficiency in Infants with Cystic Fibrosis.
A new fecal elastase 1 test using polyclonal antibodies for the detection of exocrine pancreatic insufficiency.
A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function.
An immunoassay for canine pancreatic elastase 1 as an indicator for exocrine pancreatic insufficiency in dogs.
Association of Low Fecal Elastase-1 and Non-Ulcer Dyspepsia.
Behaviour of serum pancreatic enzymes in chronic pancreatitis.
Bruising as the first sign of exocrine pancreatic insufficiency in infancy.
Can IgG4 Levels Identify the Ulcerative Colitis Subtype of Inflammatory Bowel Disease?
Can pancreatic steatosis affect exocrine functions of pancreas?
Comment on "Lw fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus (pancreas. 2008;36:274-278)".
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test.
Comparing the urinary pancreolauryl ratio and faecal elastase-1 as indicators of pancreatic insufficiency in clinical practice.
Comparison of fecal elastase 1 for exocrine pancreatic insufficiency evaluation between ex-alcoholics and chronic pancreatitis patients.
Comparison of two tubeless function tests in the assessment of mild-to-moderate exocrine pancreatic insufficiency.
Correlation Between the Standard Pancreatic Elastase-1 Enzyme-Linked Immunosorbent Assay Test and the New, Rapid Fecal Pancreatic Elastase-1 Test for Diagnosing Exocrine Pancreatic Insufficiency.
Detection and follow up of exocrine pancreatic insufficiency in cystic fibrosis: a review.
Diagnostic and Therapeutic Management of Post-Gastric Bypass Chronic Diarrhea: a Systematic Review.
Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.
Digestive enzyme replacement relieves growth failure in preterm infants with poor exocrine pancreatic function: a retrospective case series.
Endoscopic Ultrasound Findings in Patients Diagnosed with Exocrine Pancreatic Insufficiency by Low Fecal Elastase-1.
Exocrine pancreas disfunction in severely traumatised patients and early enteral nutrition.
Faecal elastase 1 in children with cystic fibrosis.
Faecal elastase 1: a marker of exocrine pancreatic insufficiency in cystic fibrosis.
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency.
Faecal elastase-1 and fat-soluble vitamin profiles in patients with cystic fibrosis in Western Norway.
Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea.
Faecal elastase-I: helpful in analysing steatorrhoea?
Faecal pancreatic elastase--1 a non invasive measure of exocrine pancreatic function.
Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.
Fecal chymotrypsin and elastase-1 determination on one single stool collected at random: diagnostic value for exocrine pancreatic status.
Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures.
Fecal elastase-1 determination: 'gold standard' of indirect pancreatic function tests?
Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease.
Fecal elastase: pancreatic status verification and influence on nutritional status in children with cystic fibrosis.
Fecal pancreatic elastase in infants under 2 years of age.
Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency.
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients.
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.
How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?
Low fecal elastase 1 levels do not indicate exocrine pancreatic insufficiency in type-1 diabetes mellitus.
Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
Now that fecal elastase is available in the United States, should clinicians start using it?
Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
Pancreatic fibrosis correlates with exocrine pancreatic insufficiency after pancreatoduodenectomy.
Pancreatic insufficiency in adult celiac disease: do patients require long-term enzyme supplementation?
Pancreatic Insufficiency Secondary to Tobacco Exposure: A Controlled Cross-Sectional Evaluation.
Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial.
Polyclonal versus monoclonal ELISA for the determination of fecal elastase 1: diagnostic value in cystic fibrosis and chronic pancreatic insufficiency.
Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population-based study.
Prevalence of exocrine pancreatic insufficiency in women with obesity syndrome: assessment by pancreatic fecal elastase 1.
Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.
Sleeve gastrectomy relieves exocrine pancreatic insufficiency in morbidly obese patients: a prospective case-control study.
Specificity of a Polyclonal Fecal Elastase ELISA for CELA3.
Staging chronic pancreatitis with exocrine function tests: Are we better?
The commercially available ELISA for pancreatic elastase 1 based on polyclonal antibodies does measure an as yet unknown antigen different from purified elastase 1. Binding studies and clinical use in patients with exocrine pancreatic insufficiency.
The need for vigilance: the case of a false-negative newborn screen for cystic fibrosis.
Transient Exocrine Pancreatic Insufficiency in Children: An Existing Entity?
[Fecal elastase-1: a useful test in pediatric practice]
[Gastroenterological function tests in the GP's office]
[The role of fecal elastase-1 in pancreatic diseases]
Gallstones
Pathological pancreatic exocrine function and duct morphology in patients with cholelithiasis.
Gastrointestinal Diseases
Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test.
Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test.
Fecal pancreatic elastase-1 levels in older individuals without known gastrointestinal diseases or diabetes mellitus.
Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.
Gastrointestinal Neoplasms
Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.
Glaucoma
[Effects of porcine pancreatic elastase-1 on elastin in human trabecular meshwork--immunohistochemical studies: Report 3. Primary open angle glaucoma]
[Effects of porcine pancreatic elastase-1 on elastin in human trabecular meshwork--immunohistochemical studies: Report 4. Pseudoexfoliation glaucoma]
Glaucoma, Open-Angle
[Effects of porcine pancreatic elastase-1 on elastin in human trabecular meshwork--immunohistochemical studies: Report 3. Primary open angle glaucoma]
Head and Neck Neoplasms
Serum elastase 1 appears specific for cancer of the pancreatic head.
Hepatitis C
Structure-activity relationships for the selectivity of hepatitis C virus NS3 protease inhibitors.
Hyperlipidemias
Hyperlipidemia does not affect development of elastase-induced abdominal aortic aneurysm in mice.
Hyperoxaluria
Enteric hyperoxaluria in chronic pancreatitis.
Hyperparathyroidism, Primary
Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal elastase 1 deficiency.
Hypersensitivity
Allergy to hedgehog with carboxypeptidase and chitinase-like and chymotrypsin-like elastase family members as the relevant allergens.
Hypertension, Pulmonary
Chronic hypoxic pulmonary hypertension in rats and increased elastolytic activity.
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor.
Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.
SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats.
Hyperthyroidism
Elastase inhibitory activity in serum of patients with thyroid dysfunction.
Infections
Elastase/antielastase systems in pulmonary diseases.
Overexpression of the celA1 gene in BCG modifies surface pellicle, glucosamine content in biofilms, and affects in vivo replication.
Protective immunity in mice vaccinated with a novel elastase-1 significantly decreases Trichinella spiralis fecundity and infection.
[Quantitative analysis of gene expression in Pomacea canaliculata infected with Angiostrongylus cantonensis and ? - tubulin gene expression in various tissues].
Inflammatory Bowel Diseases
Prevalence of pancreatic insufficiency in inflammatory bowel diseases. Assessment by fecal elastase-1.
Irritable Bowel Syndrome
Diagnostic Performance of Measurement of Fecal Elastase-1 in Detection of Exocrine Pancreatic Insufficiency: Systematic Review and Meta-analysis.
Keratoderma, Palmoplantar
Human elastase 1: evidence for expression in the skin and the identification of a frequent frameshift polymorphism.
Kidney Diseases
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1?-associated renal disease and can be symptomatic.
Liver Cirrhosis, Biliary
Pancreatic involvement in patients with Sjögren's syndrome and primary biliary cirrhosis.
Liver Diseases
A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH.
Determinants of Serum Glycerophospholipid Fatty Acids in Cystic Fibrosis.
Vitamin A status and its determinants in patients with cystic fibrosis.
Lung Injury
Effects of carbon black nanoparticles on elastase-induced emphysematous lung injury in mice.
Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome.
Recombinant human neutral endopeptidase ameliorates pancreatic elastase-induced lung injury.
Lung Neoplasms
Elastase/antielastase systems in pulmonary diseases.
Malabsorption Syndromes
Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
Malnutrition
Diagnosis and treatment of pancreatic exocrine insufficiency.
Evaluation of pancreatic functions in cases of primary and secondary malnutrition.
Exocrine pancreatic insufficiency is common in people living with HIV on effective antiretroviral therapy.
Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
Mastocytoma
Processing and activation of recombinant mouse mastocytoma histidine decarboxylase in the particulate fraction of Sf9 cells by porcine pancreatic elastase.
Melanosis
Momilactones A, B, and Tricin in Rice Grain and By-Products are Potential Skin Aging Inhibitors.
Metabolic Syndrome
CELA2A mutations predispose to early-onset atherosclerosis and metabolic syndrome and affect plasma insulin and platelet activation.
Myocardial Infarction
Elafin-overexpressing mice have improved cardiac function after myocardial infarction.
Myocarditis
A serine elastase inhibitor reduces inflammation and fibrosis and preserves cardiac function after experimentally-induced murine myocarditis.
Neoplasm Metastasis
Pancreatic ductal cell carcinoma producing pancreatic elastase 1.
Neoplasms
A clinical evaluation of serological diagnosis for pancreatic cancer.
A novel strategy for the tumor angiogenesis-targeted gene therapy: generation of angiostatin from endogenous plasminogen by protease gene transfer.
A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.
alpha 1-Proteinase inhibitor production by human adenocarcinomas xenotransplanted into nude mice.
Analysis of elastase 1 for evaluation of excretory function of the pancreas after gastropancreatoduodenal resection.
Analysis of pancreatic serum markers in patients with cystic fibrosis.
ASO Author Reflections: Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms.
Clinical usefulness of computer-assisted diagnosis using combination assay of tumor markers for pancreatic carcinoma.
Effectiveness of discriminant analysis of serum CA 19-9 and elastase 1 in diagnosis of pancreatic carcinoma.
Effectiveness of multivariate analysis of tumor markers in diagnosis of pancreatic carcinoma: a prospective study in multiinstitutions.
Elastase-1-secreting acinar cell carcinoma of the pancreas. A cytologic, electron microscopic and histochemical study.
Establishment and characterization of a cell line from a human cholangiocellular carcinoma.
Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer.
Experience with intraarterial infusion of styrene maleic acid neocarzinostatin (SMANCS)-lipiodol in pancreatic cancer.
Immunocytochemical localization of elastase 1 in human pancreas.
Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.
Pancreatic ductal cell carcinoma producing pancreatic elastase 1.
Proteases and emphysema.
Recent Trends in the Design, Synthesis and Biological Exploration of ?-Lactams.
Refinement of an orthotopic lung cancer model in the nude rat.
Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma.
Serum elastase 1 appears specific for cancer of the pancreatic head.
Serum Elastase 1 Level as a Risk Factor for Postoperative Recurrence in Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms.
Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
The Role of IL-6, 8, and 10, sTNFr, CRP, and Pancreatic Elastase in the Prediction of Systemic Complications in Patients with Acute Pancreatitis.
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma.
[A promising tumor marker CA 19-9 for pancreatic carcinoma: comparison with CEA and elastase 1]
[Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9]
[Clinical significance of elastase 1 assay as a tumor marker]
[Clinical study on tissue polypeptide antigen (TPA) as a tumor marker]
[DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
[Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]
[Establishment and characterization of a human cholangiocellular carcinoma cell line]
[Matured mediastinal teratoma with high levels of tumor markers in cystic fluid]
[Pancreatic elastase 1]
[Tumor markers for pancreatic and biliary tract cancer]
Non-alcoholic Fatty Liver Disease
A Pilot Genome-Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH.
Liver and pancreas: 'Castor and Pollux' regarding the relationship between hepatic steatosis and pancreas exocrine insufficiency.
Obesity
Prevalence of exocrine pancreatic insufficiency in women with obesity syndrome: assessment by pancreatic fecal elastase 1.
[Hepatic steatosis and fatty pancreas--2 targets of metabolic syndrom in children].
Opportunistic Infections
Pancreatic dysfunction and its association with fat malabsorption in HIV infected children.
Osteoporosis
Fecal elastase 1 and vitamin D3 in patients with osteoporotic bone fractures.
Pancreatic Cyst
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Pancreatic Diseases
A prospective trial of early detection of pancreatic cancer by ultrasonographic examination combined with measurement of serum elastase 1.
Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods.
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Diagnostic value of serum elastase 1 in pancreatic disease.
Elastase-1 vs trypsin, lipase and amylase serum levels in pancreatic diseases.
Faecal pancreatic elastase--1 a non invasive measure of exocrine pancreatic function.
Fecal calprotectin and elastase 1 determinations in patients with pancreatic diseases: a possible link between pancreatic insufficiency and intestinal inflammation.
Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection.
High prevalence of exocrine pancreatic insufficiency in diabetes mellitus. A multicenter study screening fecal elastase 1 concentrations in 1,021 diabetic patients.
Human serum alpha 1-antichymotrypsin is an inhibitor of pancreatic elastases.
Impaired fecal elastase excretion in uremic pancreopathy.
Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults.
Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
Serum elastase 1 in chronic pancreatic disease.
Serum elastase 1 in clinical practice.
Serum human pancreatic elastase I levels in pancreatic disease.
Serum immunoreactive elastase in diagnosis of pancreatic diseases. A sensitive marker for pancreatic cancer.
Serum protease inhibitor capacity for elastase and the severity of pancreatitis.
The role of fecal elastase-1 in detecting exocrine pancreatic disease.
Trypsin and elastase-1 in chronic pancreatic diseases.
Urinary elastase 1 in chronic pancreatic disease.
[Clinical evaluation of measurement of serum elastase 1 levels in pancreatic diseases. Including comparison with endoscopic retrograde pancreatogram]
[Clinical evaluation of serum elastase-1 levels in patients with acute pancreatitis]
[Determination and clinical relevance of fecal pancreatic elastase in dogs]
[Serum elastase 1 in the diagnosis of pancreatic diseases]
[The role of fecal elastase-1 in pancreatic diseases]
pancreatic elastase deficiency
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1?-associated renal disease and can be symptomatic.
Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal elastase 1 deficiency.
Usefulness of faecal elastase-1 assay in monitoring pancreatic function in childhood coeliac disease.
Pancreatic Fistula
Prediction of pancreatic fistula after pancreatoduodenectomy by preoperative dynamic CT and fecal elastase-1 levels.
Preoperative fecal elastase-1 (FE-1) adds value in predicting post-operative pancreatic fistula: not all soft pancreas share the same risk - A prospective analysis on 105 patients.
Pancreatic Neoplasms
A clinical evaluation of serological diagnosis for pancreatic cancer.
A prospective trial of early detection of pancreatic cancer by ultrasonographic examination combined with measurement of serum elastase 1.
A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer.
CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis.
Characteristic behavior of serum elastase 1 in pancreatic cancer.
Comparison of CA19-9 with other tumor markers in the diagnosis of cancer of the pancreas.
Deoxyribonuclease I serum activity in pancreatic cancer.
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Effectiveness of multivariate analysis of tumor markers in diagnosis of pancreatic carcinoma: a prospective study in multiinstitutions.
Endogenous opioids inhibit early-stage pancreatic pain in a mouse model of pancreatic cancer.
Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer.
Faecal elastase-1 is an independent predictor of survival in advanced pancreatic cancer.
Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression.
Pancreatic ductal cell carcinoma producing pancreatic elastase 1.
Pancreatic elastase and serum alpha 1-antitrypsin levels in beagle dogs smoking high- and low-nicotine cigarettes: possible mechanism of pancreatic cancer in cigarette smokers.
Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer.
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
Serum elastase 1 appears specific for cancer of the pancreatic head.
Serum elastase 1 in chronic pancreatic disease.
Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
Serum phospholipase A2 activity in chronic pancreatic diseases.
The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography.
Urinary elastase 1 in chronic pancreatic disease.
Value of ultrasonographic examination combined with measurement of serum tumor markers in the diagnosis of pancreatic cancer of less than 3 cm in diameter.
[A trial of the mass examination of pancreatic cancer using measurement of serum CA 19-9 and elastase-1 and ultrasonography]
[Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]
[Pancreatic elastase 1]
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
[Tumor marker--personal experience. Mass survey and outpatients screening of pancreatic cancer]
Pancreatitis
A prospective study of serum pancreatic elastase-1 in the diagnosis and assessment of acute pancreatitis.
Acute pancreatitis from mumps re-infection in adulthood. A case report.
Advances in the enzyme diagnosis of pancreatic diseases.
Alterations in serum pancreatic elastase 1 content in acute and chronic pancreatitis: comparison with alpha-amylase activity.
Blood concentrations of polymorphonuclear leucocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis.
CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis.
Changes in serum immunoreactive pancreatic elastase 1 in acute pancreatitis.
Comparative evaluation of the diagnosis of acute pancreatitis based on serum and urine enzyme assays.
Comparison of elastase-1 with amylase, lipase, and trypsin-like immunoreactivity in the diagnosis of acute pancreatitis.
Diagnostic and prognostic value of serum elastase 1 in acute pancreatitis.
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Diagnostic value of immunoreactive phospholipase A2 in acute pancreatitis.
Diagnostic value of pancreatic elastase-1 in human acute pancreatitis.
Diagnostic value of serum elastase 1 in pancreatic disease.
Early diagnosis of asparaginase-associated pancreatitis based on elevated serum elastase-1 levels: Case reports.
Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase.
Effectiveness of discriminant analysis of serum CA 19-9 and elastase 1 in diagnosis of pancreatic carcinoma.
Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma.
Exocrine pancreatic function during the early recovery phase of acute pancreatitis.
Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.
Hereditary pancreatitis in a young adult: Acute to chronic.
Human cationic, pancreatic elastase in acute pancreatitis.
Incomplete functional and morphological recovery after acute and acute recurrent pancreatitis in children.
Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy.
Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.
Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis.
Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.
Pancreatic ductal cell carcinoma producing pancreatic elastase 1.
Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome.
Pancreatic elastase induces liver injury by activating cytokine production within Kupffer cells via nuclear factor-Kappa B.
Pancreatic elastase is proven to be a mannose-binding protein--implications for the systemic response to pancreatitis.
Pancreatic exocrine insufficiency following acute pancreatitis: Systematic review and study level meta-analysis.
para-Sulphonato-calix[n]arene capped silver nanoparticles challenge the catalytic efficiency and the stability of a novel human gut serine protease inhibitor.
Polyclonal pancreatic elastase assay is superior to monoclonal assay for diagnosis of acute pancreatitis.
Proinflammatory effects of pancreatic elastase are mediated through TLR4 and NF-kappaB.
Protective effect of a pancreatic elastase inhibitor against a variety of acute pancreatitis in rats.
Pulmonary vascular injury in pancreatitis: evidence for a major role played by pancreatic elastase.
Questioning current concepts in acute pancreatitis: endotoxin contamination of porcine pancreatic elastase is responsible for experimental pancreatitis-associated distant organ failure.
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Serum elastase 1 appears specific for cancer of the pancreatic head.
Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.
Serum elastase in the diagnosis of acute pancreatitis: a prospective study.
Serum pancreatic enzyme assays in acute abdomen: a comparative prospective study.
Serum pancreatic enzyme behavior during the course of acute pancreatitis.
Serum protease inhibitor capacity for elastase and the severity of pancreatitis.
Specific interaction of pancreatic elastase and leucocytes to produce oxygen radicals and its implication in pancreatitis.
Specificity and sensitivity of serum canine pancreatic elastase-1 concentration in the diagnosis of pancreatitis.
Studies on immunoreactive pancreatic elastase 2 in human serum.
Studies on porcine pancreatic elastase activity. II. Immunoreactive elastase level during acute hemorrhagic pancreatitis in pigs.
The reversion variant (p.Arg90Leu) at the evolutionarily adaptive p.Arg90 site in CELA3B predisposes to chronic pancreatitis.
The Role of IL-6, 8, and 10, sTNFr, CRP, and Pancreatic Elastase in the Prediction of Systemic Complications in Patients with Acute Pancreatitis.
The role of p65 NF-kappaB/RelA in pancreatitis-induced Kupffer cell apoptosis.
The true value of serum elastase-1 in endoscopic retrograde cholangiopancreatography (ERCP).
Using faecal elastase-1 to screen for chronic pancreatitis in patients admitted with acute pancreatitis.
Value of ultrasonographic examination combined with measurement of serum tumor markers in the diagnosis of pancreatic cancer of less than 3 cm in diameter.
Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas.
Values of serum carcinoembryonic antigen and elastase 1 in diagnosis of pancreatic carcinoma.
[Changes in serum pancreatic enzymes and pancreatic secretory trypsin inhibitor in patients with severe acute pancreatitis]
[Clinical evaluation of serum elastase-1 levels in patients with acute pancreatitis]
[Clinical studies of serum phospholipase A2 immunoreactivity]
[Importance of pancreatopeptidase E for the pathogenesis of acute pancreatitis]
[Interaction of proteases and their inhibitors in the pathogenesis of pancreatitis]
[Pancreatic elastase 1]
[Significance of serum levels of elastase 1 and pancreatic isoamylase in acute and chronic recurrent pancreatitis]
[The value of estimation of serum pancreatic elastase in experimental pancreatic disorders in rats]
Pancreatitis, Acute Hemorrhagic
Studies on porcine pancreatic elastase activity. II. Immunoreactive elastase level during acute hemorrhagic pancreatitis in pigs.
Pancreatitis, Alcoholic
Pancreatic exocrine insufficiency following acute pancreatitis: Systematic review and study level meta-analysis.
[Fecal elastase-1 determination in the diagnosis of chronic pancreatitis]
Pancreatitis, Chronic
Accuracy of the plasma amino acid-consumption test in detecting pancreatic diseases is due to different methods.
Alterations in serum pancreatic elastase 1 content in acute and chronic pancreatitis: comparison with alpha-amylase activity.
Alterations of bone mineral density and bone metabolism in patients with various grades of chronic pancreatitis.
Alterations of vitamin D3 metabolism in young women with various grades of chronic pancreatitis.
Analysis of pancreatic elastase-1 concentrations in duodenal aspirates from healthy subjects and patients with chronic pancreatitis.
Comparison of Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasonography, and Fecal Elastase 1 in Chronic Pancreatitis and Clinical Correlation.
Comparison of fecal elastase 1 for exocrine pancreatic insufficiency evaluation between ex-alcoholics and chronic pancreatitis patients.
Deoxyribonuclease I serum activity in pancreatic cancer.
Diagnosis and treatment of pancreatic exocrine insufficiency.
Diagnosis of exocrine pancreatic insufficiency in chronic pancreatitis:
Diagnostic utility of a new monoclonal antibody pancreatic isoamylase assay in chronic pancreatic diseases.
Duodenal secretion and fecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis.
Effects of micronutrient status on oxidative stress and exocrine pancreatic function in patients with chronic pancreatitis.
Elastase-1 vs trypsin, lipase and amylase serum levels in pancreatic diseases.
Faecal elastase 1 in chronic pancreatitis.
Faecal elastase 1 measurement in chronic pancreatitis.
Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency.
Fecal elastase 1 determination in chronic pancreatitis.
Fecal elastase 1 measurement compared with endoscopic retrograde cholangiopancreatography for the diagnosis of chronic pancreatitis.
Fecal pancreatic elastase 1 is inaccurate in the diagnosis of chronic pancreatitis.
Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency.
Genetic Analysis of Human Chymotrypsin-Like Elastases 3A and 3B (CELA3A and CELA3B) to Assess the Role of Complex Formation between Proelastases and Procarboxypeptidases in Chronic Pancreatitis.
Immunocytochemical localization of elastase 1 in human pancreas.
Macrolipasemia in Crohn's disease.
Magnetic resonance imaging and magnetic resonance cholangiopancreatography findings compared with fecal elastase 1 measurement for the diagnosis of chronic pancreatitis.
Now that fecal elastase is available in the United States, should clinicians start using it?
Obstructed pancreaticojejunostomy partly explains exocrine insufficiency after pancreatic head resection.
Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.
Quantification of pancreatic exocrine function of chronic pancreatitis with secretin-enhanced MRCP.
Quantitative MRCP assessment of pancreatic exocrine reserve and its correlation with faecal elastase-1 in patients with chronic pancreatitis.
Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease.
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
Serum elastase 1 in chronic pancreatic disease.
Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.
Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
Serum phospholipase A2 activity in chronic pancreatic diseases.
The Lundh test and faecal elastase 1 determination in chronic pancreatitis: a comparative study.
The reversion variant (p.Arg90Leu) at the evolutionarily adaptive p.Arg90 site in CELA3B predisposes to chronic pancreatitis.
Urinary elastase 1 in chronic pancreatic disease.
Usefulness of a 13C-labeled mixed triglyceride breath test for assessing pancreatic exocrine function after pancreatic surgery.
Using faecal elastase-1 to screen for chronic pancreatitis in patients admitted with acute pancreatitis.
Validation of fecal elastase-1 determination using immunoenzymatic assay in HIV-infected patients.
Vitamin D3 in patients with various grades of chronic pancreatitis, according to morphological and functional criteria of the pancreas.
[Assay of serum elastase 1 in adenocarcinoma of the pancreas: diagnostic value, compared and combined study with serum CEA and CA 19-9]
[Clinical evaluation of serum elastase-1 levels in patients with acute pancreatitis]
[Clinical features of different variants of excretory pancreatic insufficiency]
[DIAGNOSTIC MARKERS FOR CHRONIC PANCREATITIS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH DIFFERENT PHENOTYPE].
[Effect of pancreatic substitutes on fecal and serum elastase and on pain in patients with chronic pancreatitis]
[Fecal elastase-1 determination in the diagnosis of chronic pancreatitis]
[Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas]
Pemphigoid, Bullous
Comparative molecular docking analysis of essential oil constituents as elastase inhibitors.
Pneumonia
Curcumin attenuates elastase- and cigarette smoke-induced pulmonary emphysema in mice.
Effects of phosphoinositide 3-kinase in protease-induced acute and chronic lung inflammation, remodeling and emphysema in rats.
Elastase/antielastase systems in pulmonary diseases.
Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.
Role of CD69 in the pathogenesis of elastase-induced pulmonary inflammation and emphysema.
X-Ray Dark-field Imaging to Depict Acute Lung Inflammation in Mice.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Early diagnosis of asparaginase-associated pancreatitis based on elevated serum elastase-1 levels: Case reports.
Pseudomonas Infections
Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation.
Pseudoxanthoma Elasticum
Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins.
Psoriasis
Inhibition of Neutrophil Elastase and Cathepsin G As a New Approach to the Treatment of Psoriasis: From Fundamental Biology to Development of New Target-Specific Drugs.
Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study.
Pulmonary Disease, Chronic Obstructive
Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease.
Characterization of peptide fragments from lung elastin degradation in chronic obstructive pulmonary disease.
Effects of Chung-Pae Inhalation Therapy on a Mouse Model of Chronic Obstructive Pulmonary Disease.
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure.
IFN Regulatory Factor 3 Potentiates Emphysematous Aggravation by Lipopolysaccharide.
Intrapulmonary distal airway stem cell transplantation repairs lung injury in chronic obstructive pulmonary disease.
Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture.
S-Allylmercapto-N-acetylcysteine ameliorates elastase-induced chronic obstructive pulmonary disease in mice via regulating autophagy.
Subunit structure of calgranulins A and B obtained from sputum, plasma, granulocytes and cultured epithelial cells.
The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.
[Effects of tumor necrosis factor alpha on proteolysis of respiratory muscles in rats with chronic obstructive pulmonary disease]
[Protective and therapeutic effect of pulmonary surfactant on the experimental chronic obstructive pulmonary disease in hamsters]
Pulmonary Edema
Neutral endopeptidase determines the severity of pancreatitis-associated lung injury.
Pulmonary Emphysema
Adenovirus-mediated transfer and overexpression of heme oxygenase 1 cDNA in lungs attenuates elastase-induced pulmonary emphysema in mice.
An emphysema model in rats treated intratracheally with elastase.
Comprehensive analysis of elastase-induced pulmonary emphysema in mice: effects of ambient existing particulate matters.
Development of a canine model of pulmonary emphysema and imaging of the emphysematous lung with infrared thoracoscopy.
Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats.
Effects of intravenous prostaglandins F2 alpha and E2 in hypoxic and non-hypoxic rabbits with elastase induced emphysema.
Elastase/antielastase systems in pulmonary diseases.
Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters.
Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277.
Intrapleural injection of elastase: a model for inducing subpleural emphysema?
Irreversible bronchial goblet cell metaplasia in hamsters with elastase-induced panacinar emphysema.
Prevention of elastase-induced emphysema in placenta growth factor knock-out mice.
Pulmonary ventilation and blood gas values in emphysematous hamsters.
Risk Assessment for Use of a Porcine Circovirus-Contaminated Reagent in a Barrier Maintained Rodent Colony.
Testosterone deficiency promotes the development of pulmonary emphysema in orchiectomized mice exposed to elastase.
The effect of 60% oxygen on air-space enlargement and cross-linked elastin synthesis in hamsters with elastase-induced emphysema.
Tolerance to ozone in emphysematous rats.
Ultrastructural studies of elastase-induced experimental emphysema.
Pulmonary Fibrosis
Elastase/antielastase systems in pulmonary diseases.
Renal Insufficiency
Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.
Serum elastase 1 in inflammatory pancreatic and gastrointestinal diseases and in renal insufficiency. A comparison with other serum pancreatic enzymes.
[Effect of chronic renal failure and hemodialysis on the pancreas-specific enzyme pattern in the serum]
Renal Insufficiency, Chronic
Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease.
Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.
Respiratory Distress Syndrome
Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass.
Pancreatic elastase activates pulmonary nuclear factor kappa B and inhibitory kappa B, mimicking pancreatitis-associated adult respiratory distress syndrome.
Severe Acute Malnutrition
Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
Skin Diseases
Human elastase 1: evidence for expression in the skin and the identification of a frequent frameshift polymorphism.
Steatorrhea
Association between steatorrhea, growth, and immunologic status in children with perinatally acquired HIV infection.
Does an association exist between chronic pancreatitis and liver cirrhosis in alcoholic subjects?
Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes?
Exocrine pancreatic function in children with progressive familial intrahepatic cholestasis type 2.
Fecal elastase-1 is useful in the detection of steatorrhea in patients with pancreatic diseases but not after pancreatic resection.
High prevalence of steatorrhea in 101 diabetic patients likely to suffer from exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations: a prospective multicenter study.
Long-Term Functional Outcome After Pancreatoduodenectomy for Periampullary Carcinoma With Morphological Correlation.
Now that fecal elastase is available in the United States, should clinicians start using it?
Pancreatin therapy in patients with insulin-treated diabetes mellitus and exocrine pancreatic insufficiency according to low fecal elastase 1 concentrations. Results of a prospective multi-centre trial.
Stomach Neoplasms
Serial changes in plasma levels of pancreatic elastase 1 after pancreatic surgeries.
Thrombosis
Possible risk of thrombosis in human subjects administered pancreatic elastase.
Trichinellosis
Molecular characterization of a Trichinella spiralis elastase-1 and its potential as a diagnostic antigen for trichinellosis.
Tuberculosis
Overexpression of the celA1 gene in BCG modifies surface pellicle, glucosamine content in biofilms, and affects in vivo replication.
Tuberculosis, Pulmonary
Elastase/antielastase systems in pulmonary diseases.
Uremia
Impaired fecal elastase excretion in uremic pancreopathy.
Varicose Veins
[Active pancreatopeptidase E levels in the blood serum of patients with varicose veins of the lower extremities]
Vascular Diseases
Overexpression of the serine elastase inhibitor elafin protects transgenic mice from hypoxic pulmonary hypertension.
Pancreatic exocrine function in patients with diabetes.
Suppressed smooth muscle proliferation and inflammatory cell invasion after arterial injury in elafin-overexpressing mice.
Vascular System Injuries
Pulmonary vascular injury in pancreatitis: evidence for a major role played by pancreatic elastase.